Zepbound’s greater weight loss is a huge advantage for Eli Lilly, which is competing with Novo Nordisk for a larger share of the weight loss drug market.
Related Posts
UFC’s Dana White joins Meta’s board weeks before Trump takes office
UFC CEO Dana White, a longtime friend of Donald Trump, is joining the board of Meta two weeks before the new administration begins.
Netflix has never looked better, so it may be time to take some profits, says Loop Capital
Now is the time for investors to step to the sidelines on Netflix, according to the investment bank.
Dick’s Sporting Goods stands by full-year guidance — even with tariffs looming
Dick’s Sporting Goods reaffirmed its sales and profit guidance for fiscal 2025 and said the figures take into account all current tariffs in effect.